ISM- MSBV. - ALL - PAR_RETI-- 2025-09-17

Summary by AI ^BETAClose X

Morgan Stanley B.V. announced a partial cancellation of several ISINs/CUSIPs, with a settlement date of September 19, 2025. For ISIN XS2877420534, the unwind amount is 50,000.00, leaving an outstanding amount of 326,000.00. ISIN XS2877363049 has an unwind amount of 35,000.00, resulting in an outstanding amount of 1,850,000.00. The unwind amount for ISIN XS2893910963 is 350,000.00, with an outstanding amount of 9,601,000.00. ISIN XS2917981289 sees an unwind of 200,000.00, bringing the outstanding amount to 425,000.00. Lastly, ISIN XS2918085064 has an unwind amount of 150,000.00, leaving an outstanding amount of 50,000.00.

Disclaimer*

Morgan Stanley B.V.

17 September 2025

Morgan Stanley & Co. International plc

25 Cabot Square

Canary Wharf

London E14 4QA, England

September 17, 2025

Notice of Partial Cancellation

Dear Sir/Madam:

Please note that there has been a Partial Cancellation by the issuer for the following ISIN(s) / CUSIP(s):

ISIN(s)/CUSIP(s)	Issuer	Unwind Amount	Outstanding Amount*	Settlement Date
XS2877420534	MORGAN STANLEY B.V.	50,000.00	326,000.00	19-Sep-2025
XS2877363049	MORGAN STANLEY B.V.	35,000.00	1,850,000.00	19-Sep-2025
XS2893910963	MORGAN STANLEY B.V.	350,000.00	9,601,000.00	19-Sep-2025
XS2917981289	MORGAN STANLEY B.V.	200,000.00	425,000.00	19-Sep-2025
XS2918085064	MORGAN STANLEY B.V.	150,000.00	50,000.00	19-Sep-2025

*Outstanding Amount reflects the Outstanding Issuance Amount post notification event.

In case of any questions do not hesitate to contact us for further information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END